中外医学研究2024,Vol.22Issue(12) :168-172.DOI:10.14033/j.cnki.cfmr.2024.12.042

中西医治疗难治性幽门螺杆菌感染的研究进展

Research Progress of Traditional Chinese and Western Medicine in the Treatment of Refractory Helicobacter Pylori Infection

程杨妮 张霖
中外医学研究2024,Vol.22Issue(12) :168-172.DOI:10.14033/j.cnki.cfmr.2024.12.042

中西医治疗难治性幽门螺杆菌感染的研究进展

Research Progress of Traditional Chinese and Western Medicine in the Treatment of Refractory Helicobacter Pylori Infection

程杨妮 1张霖2
扫码查看

作者信息

  • 1. 湖北民族大学医学部 湖北 恩施 445000
  • 2. 襄阳市中医医院(襄阳市中医药研究所)
  • 折叠

摘要

难治性幽门螺杆菌(Helicobacter pylori,Hp)感染治疗是世界医学范围内的一个难解问题,Hp感染会导致一系列消化系疾病.由于Hp耐药性等相关原因,近年来根除Hp感染治疗指南也不断更新,临床上仍有一部分患者多次使用根除治疗方案仍未根除成功,并且呈现逐年增长的趋势,因此,寻找一种新思路研究有效的治疗方案已成为目前急需解决的问题.本文从难治性Hp感染耐药的原因、治疗难治性Hp感染研究现状进行归纳总结,为临床上治疗难治性Hp感染提供新思路.

Abstract

The treatment of refractory Helicobacter pylori(Hp)infection is a difficult problem worldwide,and Hp infection can lead to a series of digestive system diseases.Due to factors such as Hp resistance,the treatment guidelines for eradicating Hp infection have been constantly updated in recent years,there are still some patients who have repeatedly used eradication treatment plans but have not been successfully eradicated,and the trend is increasing year by year,therefore,finding a new approach to research effective treatment plans has become an urgent problem to be solved.This article summarized the reasons for drug resistance in refractory Hp infection and the current research status in the treatment of refractory Hp infection,providing new ideas for the clinical treatment of refractory Hp infection.

关键词

难治性/幽门螺杆菌/感染/中西医

Key words

Refractory/Helicobacter pylori/Infection/Traditional Chinese and western medicine

引用本文复制引用

基金项目

湖北省自然科学基金创新发展联合基金(2022)(2022CFD116)

出版年

2024
中外医学研究
中国医院管理杂志社

中外医学研究

影响因子:1.149
ISSN:1674-6805
参考文献量35
段落导航相关论文